A Prospective, Multicenter Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
Galderma R&D
Summary
The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.
Eligibility
- Age range
- 22+ years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: 1. Males or non-pregnant, non-breastfeeding females, 22 years of age or older. 2. Intent to receive treatment for augmentation and correction of retrusion in the chin region. Exclusion Criteria: 1. Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel or to gram positive bacterial proteins. 2. Known/previous allergy or hypersensitivity to local anesthetics, e.g. lidocaine or other amide-type anesthetics. 3. Previous or present multiple allergies or severe allergies, such as manifested by anaphylaxis or angioedema, or family history of thes…
Interventions
- DeviceRestylane Lyft with Lidocaine
Sterile gel of hyaluronic acid.
Locations (8)
- Galderma Investigational Site # 8680Westport, Connecticut
- Galderma Investigational Site # 8774Boynton Beach, Florida
- Galderma Investigational Site # 7030Coral Gables, Florida
- Galderma Investigational Site # 8682Coral Gables, Florida
- Galderma Investigational Site # 7042Atlanta, Georgia
- Galderma Investigational Site # 7043Bethesda, Maryland